Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Vortioxetine in Schizophrenia

NCT02357797 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT02357797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02357797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Vortioxetine in Schizophrenia
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Unknown status
Start date
February 29, 2016
Completion date
June 1, 2024
Enrollment
88 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

negative symptoms, schizophrenia